PeptideDB

HDAC-IN-82

HDAC-IN-82

CAS No.:

HDAC-IN-82 (Compound 18b) is a histone deacetylase (HDAC) inhibitor with selective anti-plasmodium and anti-cancer activ
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

HDAC-IN-82 (Compound 18b) is a histone deacetylase (HDAC) inhibitor with selective anti-plasmodium and anti-cancer activities. HDAC-IN-82 exhibits potent anti-proliferative and caspase 3/7 activity in tumor cells. HDAC-IN-82 causes hyperacetylation of histone H3 and α-tubulin.

Physicochemical Properties


Molecular Formula C24H31N7O4
Molecular Weight 481.55
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets Caspase 3 Caspase-7
References

[1]. Multicomponent syntheses enable the discovery of novel quisinostat-derived chemotypes as histone deacetylase inhibitors. Eur J Med Chem. 2025 Jan 5;281:117045.


Solubility Data


Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.0766 mL 10.3831 mL 20.7663 mL
5 mM 0.4153 mL 2.0766 mL 4.1533 mL
10 mM 0.2077 mL 1.0383 mL 2.0766 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.